Find a list of your saved stories here

Fluor-Designed and Built Plasma Fractionation Facility Awarded ISPE 2014 Facility of the Year for Project Execution

Fluor-Designed and Built Plasma Fractionation Facility Awarded ISPE 2014 Facility of the Year for Project Execution

1 photo
Save Story

Save stories to read later

Estimated read time: 4-5 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

IRVING, Texas--(BUSINESS WIRE)--Apr 10, 2014--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical Engineering (ISPE) 2014 Facility of the Year for Project Execution.

Fluor designed and built this plasma fractionation facility in North Carolina for Grifols that was awarded ISPE's 2014 Facility of the Year for Project Execution. (Photo: Business Wire)

Fluor provided integrated engineering, procurement, construction management and front-end qualification for this 150,000-square-foot plasma fractionation facility, which was built using modular construction techniques to meet an aggressive construction schedule, incorporate new centrifuge technology and expand existing plant utilities.

“Fluor provides project management and execution excellence for pharmaceutical and biotech clients across the globe, and the Grifols blood plasma facility in North Carolina is a great example of successful outcomes,” said Juan G. Hernandez, president of Industrial Services for Fluor. “We provided Grifols with a single point of project accountability, continuity of intent and elimination of redundant project functions that resulted in a state-of-the-art facility.”

“Grifols has very high standards, and we can always rely upon the same high standards from Fluor in delivering our project execution needs,” said Detlef Kehm, Grifols vice president of engineering. “I am personally very pleased with ISPE’s independent validation of this superior project and with Fluor’s performance.”

ISPE’s judging panel was impressed with the delivery of the facility in an aggressive time frame and under budget. This was achieved with a high degree of collaboration within the teams and because of early and consistent collaboration with European and North American regulatory agencies, which facilitated the qualification and validation process.

Grifols’ North Fractionation Facility in North Carolina is the world’s largest and most technologically advanced of its kind. It operates with a closed and fully automated manufacturing process in an ambient environment to deliver life sciences products in the safest, quality conscious and efficient manner. The primary project achievements included the following:

Provided a high-throughput manufacturing facility while ensuring superior product quality Maximized yields while maintaining product quality Lowered long-term operational costs Delivered the facility in an aggressive timeframe and under budget Fluor-led projects have been chosen by ISPE for Facility of the Year awards three times over the past five years.

For more details and a video on the Grifols North Fractionation Facility project, visit\_fluor/Pages/videos.aspx?channel=4&videoid=115.

About Grifols

Grifols is a global healthcare company with a 70-year legacy of improving people's health and wellbeing through the development of life-saving plasma medicines, diagnostics systems and hospital pharmacy products. Additionally, Grifols has established an independent engineering company, Grifols Engineering, SA. The company is present in more than 100 countries worldwide and is headquartered in Barcelona, Spain. In 2013, sales exceeded 2,740 million euros with a headcount of 13,200 employees. The company's class A shares are listed on the Spanish Stock Exchange, where they are part of the Ibex-35 (MCE:GRF). Its non-voting class B shares are listed on the Mercado Continuo (MCE:GRF.P) and on the U.S. NASDAQ via ADRs (NASDAQ: GRFS). For more information, visit

About Fluor Corporation

Fluor Corporation (NYSE: FLR) is a global engineering and construction firm that designs and builds some of the world's most complex projects. The company creates and delivers innovative solutions for its clients in engineering, procurement, fabrication, construction, maintenance and project management on a global basis. For more than a century, Fluor has served clients in the energy, chemicals, government, industrial, infrastructure, mining and power market sectors. Headquartered in Irving, Texas, Fluor ranks 110 on the FORTUNE 500 list. With more than 40,000 employees worldwide, the company's revenue for 2013 was $27.4 billion. Visit Fluor at and follow on Twitter @FluorCorp.

Photos/Multimedia Gallery Available:

CONTACT: Fluor Corporation

Media Relations:

Brian Mershon, 469-398-7621


Eric Krantz, 281-263-6030


Investor Relations:

Ken Lockwood, 469-398-7220


Jason Landkamer, 469-398-7222



SOURCE: Fluor Corporation

Copyright Business Wire 2014

PUB: 04/10/2014 04:37 PM/DISC: 04/10/2014 04:37 PM

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Most recent Business stories

Related topics

Fluor Corporation


    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the Trending 5.
    By subscribing, you acknowledge and agree to's Terms of Use and Privacy Policy.

    KSL Weather Forecast